Knockout Tested Rabbit Recombinant Monoclonal WTAP phospho S306 antibody. Suitable for WB, IP, Dot and reacts with Human, Synthetic peptide - Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
WB | IP | Dot | Flow Cyt (Intra) | ICC/IF | IHC-P | |
---|---|---|---|---|---|---|
Human | Tested | Tested | Expected | Not recommended | Not recommended | Not recommended |
Mouse | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Rat | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended | Not recommended |
Synthetic peptide - Human | Not recommended | Not recommended | Tested | Not recommended | Not recommended | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide - Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/30 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide - Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Synthetic peptide - Human | Dilution info 1/1000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Synthetic peptide - Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Synthetic peptide - Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Synthetic peptide - Human | Dilution info - | Notes - |
Select an associated product type
Associated component of the WMM complex, a complex that mediates N6-methyladenosine (m6A) methylation of RNAs, a modification that plays a role in the efficiency of mRNA splicing and RNA processing (PubMed:29507755). Required for accumulation of METTL3 and METTL14 to nuclear speckle (PubMed:24316715, PubMed:24407421, PubMed:24981863). Acts as a mRNA splicing regulator (PubMed:12444081). Regulates G2/M cell-cycle transition by binding to the 3' UTR of CCNA2, which enhances its stability (PubMed:17088532). Impairs WT1 DNA-binding ability and inhibits expression of WT1 target genes (PubMed:17095724).
KIAA0105, WTAP, Pre-mRNA-splicing regulator WTAP, Female-lethal(2)D homolog, WT1-associated protein, Wilms tumor 1-associating protein, hFL(2)D
Knockout Tested Rabbit Recombinant Monoclonal WTAP phospho S306 antibody. Suitable for WB, IP, Dot and reacts with Human, Synthetic peptide - Human samples.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 59% PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Dot blot analysis of WTAP (phospho S306) using ab316275 at 1:1000 (0.525 ug/ml) followed by a Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1:1000 dilution.
This blot was developed using a high sensitivity ECL substrate. The high-sensitivity ECL substrate used allows for the
detection of proteins in the mid-femtogram range.
All lanes: Dot Blot - Anti-WTAP (phospho S306) antibody [EPR27038-188] (ab316275) at 1/1000 dilution
Lane 1: WTAP (phospho S306) peptide a
Lane 2: WTAP (phospho S306) peptide b
Lane 3: WTAP (phospho S305) peptide
Lane 4: WTAP non-phospho peptide
All lanes: Dot Blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/1000 dilution
Developed using the ECL technique.
Exposure time: 180s
In Western blot, ab316275 was shown to bind specifically to WTAP. Target of interest was observed at 55 kDa in wild-type HAP1 cell lysates (lanes 1-2 ) with no signal observed at this size in WTAP knockout cell line lysates (lanes 3-4 ).
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (Anti-GAPDH antibody [EPR16891] - Loading Control ab181602) staining at 1/200000 dilution.
All lanes: Western blot - Anti-WTAP (phospho S306) antibody [EPR27038-188] (ab316275) at 1/1000 dilution
Lane 1: Untreated Wild-type HAP1 (human chronic myelogenous leukemia near-haploid cell) whole cell lysate (untreated membrane) at 20 µg with 5% NFDM/TBST
Lane 2: Wild-type HAP1 treated with 200 ng/ml PMA for 30 minutes whole cell lysate (untreated membrane) at 20 µg with 5% NFDM/TBST
Lane 3: Untreated WTAP knockout HAP1 whole cell lysate (untreated membrane) at 20 µg with 5% NFDM/TBST
Lane 4: WTAP knockout HAP1 treated with 200 ng/ml PMA for 30 minutes whole cell lysate (untreated membrane) at 20 µg with 5% NFDM/TBST
Lane 5: Untreated Wild-type HAP1 (human chronic myelogenous leukemia near-haploid cell) whole cell lysate (alkaline phosphatase treated membrane) at 20 µg with 5% NFDM/TBST
Lane 6: Wild-type HAP1 treated with 200 ng/ml PMA for 30 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg with 5% NFDM/TBST
Lane 7: Untreated WTAP knockout HAP1 whole cell lysate (alkaline phosphatase treated membrane) at 20 µg with 5% NFDM/TBST
Lane 8: WTAP knockout HAP1 treated with 200 ng/ml PMA for 30 minutes whole cell lysate (alkaline phosphatase treated membrane) at 20 µg with 5% NFDM/TBST
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Performed under reducing conditions.
Observed band size: 55 kDa, 36 kDa
Exposure time: 10s
In Western blot, Anti-WTAP antibody [EPR18744] - Loading Control (Anti-WTAP antibody [EPR18744] ab195380) staining at 1/1000 dilution.
All lanes: Western blot - Anti-WTAP (phospho S306) antibody [EPR27038-188] (ab316275) at 1/1000 dilution
Lane 1: Jurkat (human t cell leukemia t lymphocyte from peripheral blood) whole cell lysate (untreated membrane) at 20 µg with 5% NFDM/TBST
Lane 2: Jurkat whole cell lysate (alkaline phosphatase treated membrane) at 20 µg with 5% NFDM/TBST
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 55 kDa
Exposure time: 26s
In Western blot, Anti-WTAP antibody [EPR18744] - Loading Control (Anti-WTAP antibody [EPR18744] ab195380) staining at 1/1000 dilution.
All lanes: Western blot - Anti-WTAP (phospho S306) antibody [EPR27038-188] (ab316275) at 1/1000 dilution
Lane 1: A375 (human malignant melanoma epithelial cell) whole cell lysate (untreated membrane) at 20 µg with 5% NFDM/TBST
Lane 2: A375 whole cell lysate (alkaline phosphatase treated membrane) at 20 µg with 5% NFDM/TBST
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Observed band size: 55 kDa
Exposure time: 26s
WTAP (phospho S306) was immunoprecipitated from 0.35 mg HAP1(human chronic myelogenous leukemia near-haploid cell) treated with 200 ng/ml PMA for 30 minutes whole cell lysate with ab316275 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab316275 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(VeriBlot for IP Detection Reagent (HRP) ab131366) was used at 1/5000 dilution.
Lane 1: HAP1(human chronic myelogenous leukemia near-haploid cell) treated with 200 ng/ml PMA for 30 minutes whole cell lysate
Lane 2: ab316275 IP in HAP1(human chronic myelogenous leukemia near-haploid cell) treated with 200 ng/ml PMA for 30 minutes whole cell lysate
Lane 3: Rabbit monoclonal IgG (Rabbit IgG, monoclonal [EPR25A] - Isotype Control ab172730) instead of ab316275 in HAP1 treated with 200 ng/ml PMA for 30 minutes whole cell lysate
All lanes: Immunoprecipitation - Anti-WTAP (phospho S306) antibody [EPR27038-188] (ab316275) at 1/30 dilution
All lanes: HAP1(human chronic myelogenous leukemia near-haploid cell) treated with 200 ng/ml PMA for 30 minutes whole cell lysate with 5% NFDM/TBST
All lanes: Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (VeriBlot for IP Detection Reagent (HRP) ab131366)
Exposure time: 180s
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com